30 Sep, EOD - Indian

Nifty Midcap 100 56529.3 (-0.01)

Nifty Pharma 21454.25 (-0.10)

SENSEX 80267.62 (-0.12)

Nifty Bank 54635.85 (0.32)

Nifty Smallcap 100 17562.75 (0.08)

Nifty 50 24611.1 (-0.10)

Nifty IT 33655.1 (-0.11)

Nifty Next 50 67845.15 (0.01)

30 Sep, EOD - Global

NIKKEI 225 44932.63 (-0.25)

HANG SENG 26855.56 (0.87)

S&P 6691.02 (0.13)

Login/Signup
Careers

Economy News

You are Here : Home > News > Economy News >

(26 Sep 2025, 12:11)

US declares 100% tariff On branded Pharma imports

US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical drugs, starting October 1, 2025. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America, could be significantly impacted by the move. Starting October 1st, 2025, we will be imposing a 100 per cent Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America, Trump noted on Truth Social.
More News

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-8657545825
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
subscription@capitalmarket.com

For Capital Market Online Product related queries :
financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +